Physician profile
Angela Many
NPI 1598762361
$3,694.93
in general payments reported to CMS, 2019-2025
25 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.95 · 2021: $476 · 2022: $2,250 · 2023: $379 · 2024: $213 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.46 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,764.86 | 2022-2023 | |
| Abbvie INC. | $550.34 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $260.29 | 2023-2025 | Gemtesa, Myfembree |
| Exeltis, USA INC. | $137.03 | 2024-2025 | Slynd |
| Astellas Pharma US INC | $101.98 | 2023-2024 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $101.77 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $97.04 | 2021-2023 | |
| Boston Scientific Corporation | $87.68 | 2019-2025 | General - Female Sui |
| Coloplast Corp | $80.00 | 2022-2025 | Restorelle, Saffron |
| Organon LLC | $79.80 | 2022-2024 | |
| Myovant Sciences INC. | $75.57 | 2022 | |
| Sage Therapeutics, LLC | $63.28 | 2025 | Zurzuvae |
| Smith+Nephew, INC. | $41.97 | 2025 | Pico |
| Shield Therapeutics INC | $40.33 | 2023 | Accrufer |
| Davol INC. | $38.92 | 2025 | Arista |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $33.25 | 2022 | |
| Roche Diagnostics Corporation | $21.62 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $19.02 | 2023 | Vivjoa |
| Pacira Pharmaceuticals Incorporated | $17.15 | 2021 | |
| Gynesonics, INC. | $16.05 | 2022 | |
| Agile Therapeutics, INC. | $14.80 | 2022 | |
| Hologic Sales and Service, LLC | $14.58 | 2021 | |
| Minerva Surgical, INC | $13.63 | 2023 | |
| Dysis Medical, INC. | $12.06 | 2021 | |
| Evofem Biosciences, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Many listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.